Abstract CT012: Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792)
Shapiro, Geoffrey, Wesolowski, Robert, Middleton, Mark, Devoe, Craig, Constantinidou, Anastasia, Papadatos-Pastos, Dionysis, Fricano, Marjorie, Zhang, Yanqiong, Karan, Sharon, Pollard, John, Penney, Marina, Asmal, Mohammed, Renshaw, F. Gary, Fields, Scott Z., Yap, Timothy A.
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article